BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2008
View Archived Issues
Clinical data on besifloxacin in bacterial conjunctivitis reported
Read More
Neuronal nicotinic receptor ligands profiled at AstraZeneca
Read More
Novel analgesic agents imparted in recent Glenmark, Merck and GSK patents
Read More
New therapeutic agents for neurological disorders reported by Taisho and Novartis
Read More
Recent Kowa and AstraZeneca patents impart new treatments for respiratory and allergic disorders
Read More
Novartis provides update of recent pipeline activity
Read More
First-in-human results of NGF enhancer KRX-0501 for the treatment of neurological disorders
Read More
PF-00868554 active, well tolerated in double-blind HCV study
Read More
Advitech and Laboratoires Urgo sign collaboration agreement in wound healing
Read More
HCV candidate BMS-790052 well tolerated in proof-of-concept study
Read More
PRT-201 shows potential to improve arteriovenous fistula surgery results
Read More
Positive phase III results reported for JZP-6 in fibromyalgia
Read More
FDA accepts Vanda's resubmission of NDA for iloperidone
Read More
Arpida provides update on iclaprim's regulatory pathway
Read More
FDA grants approval to SuperGen to initiate clinical trials of Pim inhibitor SGI-1776
Read More
Synta initiates treatment of patients in phase I/II trial of elesclomol in prostate cancer
Read More
Biovitrum reports positive results from clinical trial of Sym-001 in HDN
Read More
EMEA advises Santhera of negative opinion for idebenone MAA in Friedreich's ataxia
Read More
Enrollment suspended following DMC review of phase III MONET trial of motesanib
Read More
Aastrom treats first patient in U.S. phase II IMPACT-DCM trial
Read More
Takeda submits European MAA for once-daily Competact formulation
Read More
Nplate receives positive CHMP opinion for MAA in Europe
Read More
RoActemra receives positive opinion in Europe for rheumatoid arthritis
Read More
Rasilez HCT receives positive CHMP opinion for treatment of high blood pressure
Read More
FDA approves tapentadol immediate-release tablets for acute pain
Read More
Invitrogen and Applied Biosystems complete merger
Read More